Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finlay

Showing results (351-360 of 394) with videos related to

Pageof 40
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 28, 2007
Benzopyran sulfonamides as KV1.5 potassium channel blockersJohn Lloyd, Karnail S Atwal, Heather J Finlay, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonistsHeather J Finlay, Ji Jiang, Yolanda Caringal, et al.
Journal of Biomolecular Screening|May 20, 2011
Developing cell-specific antibodies to endothelial progenitor cells using avian immune phage display technologyTyrone Bowes, Shirley A Hanley, Aaron Liew, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancerB C Baguley, E S Marshall, J R Whittaker, et al.
Cancer|July 9, 1998
Treatment of diencephalic syndrome with chemotherapy: growth, tumor response, and long term controlA L Gropman, R J Packer, H S Nicholson, et al.
Journal of Pharmaceutical Sciences|January 11, 2018
Oral Delivery of Highly Lipophilic, Poorly Water-Soluble Drugs: Self-Emulsifying Drug Delivery Systems to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a Cholesteryl Ester Transfer Protein Inhibitor in Preclinical SpeciesXue-Qing Chen, Theresa Ziemba, Christine Huang, et al.
The Journal of Biological Chemistry|October 31, 2015
A Combination of Structural and Empirical Analyses Delineates the Key Contacts Mediating Stability and Affinity Increases in an Optimized Biotherapeutic Single-chain Fv (scFv)Chao Tu, Virginie Terraube, Amy Sze Pui Tam, et al.
Cancer Cell|November 19, 2011
Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesisCharbel Darido, Smitha R Georgy, Tomasz Wilanowski, et al.
Bioorganic & Medicinal Chemistry Letters|June 3, 2014
Design, synthesis and evaluation of phenethylaminoheterocycles as K(v)1.5 inhibitorsJames A Johnson, Ningning Xu, Yoon Jeon, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective KV1.5 blockersJohn Lloyd, Heather J Finlay, Wayne Vacarro, et al.
Pageof 40

Showing results (351-360 of 394) with videos related to

Sort By:
Pageof 40
Bioorganic & Medicinal Chemistry Letters|April 28, 2007
Benzopyran sulfonamides as KV1.5 potassium channel blockersJohn Lloyd, Karnail S Atwal, Heather J Finlay, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonistsHeather J Finlay, Ji Jiang, Yolanda Caringal, et al.
Journal of Biomolecular Screening|May 20, 2011
Developing cell-specific antibodies to endothelial progenitor cells using avian immune phage display technologyTyrone Bowes, Shirley A Hanley, Aaron Liew, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancerB C Baguley, E S Marshall, J R Whittaker, et al.
Cancer|July 9, 1998
Treatment of diencephalic syndrome with chemotherapy: growth, tumor response, and long term controlA L Gropman, R J Packer, H S Nicholson, et al.
Journal of Pharmaceutical Sciences|January 11, 2018
Oral Delivery of Highly Lipophilic, Poorly Water-Soluble Drugs: Self-Emulsifying Drug Delivery Systems to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a Cholesteryl Ester Transfer Protein Inhibitor in Preclinical SpeciesXue-Qing Chen, Theresa Ziemba, Christine Huang, et al.
The Journal of Biological Chemistry|October 31, 2015
A Combination of Structural and Empirical Analyses Delineates the Key Contacts Mediating Stability and Affinity Increases in an Optimized Biotherapeutic Single-chain Fv (scFv)Chao Tu, Virginie Terraube, Amy Sze Pui Tam, et al.
Cancer Cell|November 19, 2011
Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesisCharbel Darido, Smitha R Georgy, Tomasz Wilanowski, et al.
Bioorganic & Medicinal Chemistry Letters|June 3, 2014
Design, synthesis and evaluation of phenethylaminoheterocycles as K(v)1.5 inhibitorsJames A Johnson, Ningning Xu, Yoon Jeon, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective KV1.5 blockersJohn Lloyd, Heather J Finlay, Wayne Vacarro, et al.
Pageof 40